Education
About Us
Working with TipRanks
Follow Us
Mark Christopher Capone Insider Profile
4 Followers
Mark Christopher Capone, President & C.E.O. at Myriad Genetics, holds 3.43K shares in Mesa Laboratories (Ticker: MLAB), holds 82.05K shares in DermTech (Ticker: DMTKQ), holds 522.22K shares in Myriad Genetics (Ticker: MYGN). Most recently, Mark Christopher Capone Bought ― shares of Mesa Laboratories on Mar 10, 2026 for an estimated value of $99.33K.
Mark Christopher Capone Myriad Genetics (MYGN)President & C.E.O.
Myriad Genetics (MYGN)
President & C.E.O.
Ranked #15,582 out of 106,487 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+20.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Christopher Capone holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Christopher Capone
Mark Christopher Capone's Trading History
Myriad Genetics
Oct 01, 2019
President & C.E.O.
Uninformative Sell
773.64K
$2.39M
DermTech
Jun 05, 2023
―
Uninformative Buy
―
$1.64K
Mesa Laboratories
Mar 10, 2026
Director
Informative Buy
99.33K
$274.32K
List of latest transactions for each holding click on a transaction to see Mark Christopher Capone's performance on stock
You May Also Like
Mark Christopher Capone insider profile FAQ
What is the percentage of profitable transactions made by Mark Christopher Capone?
The percentage of profitable transactions made by Mark Christopher Capone is 83%.
What is the average return per transaction made by Mark Christopher Capone?
The average return per transaction made by Mark Christopher Capone is 20.10%.
What stocks does Mark Christopher Capone hold?
Mark Christopher Capone holds: MYGN, DMTKQ, MLAB stocks.
What was Mark Christopher Capone’s latest transaction?
Mark Christopher Capone latest transaction was an Informative Buy of $99.33K.
What was Mark Christopher Capone's most profitable transaction?
Mark Christopher Capone’s most profitable transaction was an Informative Sell of MYGN stock on July 13, 2018. The return on the trade was 39.70%.
What is Mark Christopher Capone's role in Myriad Genetics?
Mark Christopher Capone's role in Myriad Genetics is President & C.E.O..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.